LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU=McRae Simon
  2. AU="Shorubalko, Ivan"
  3. AU="Stewart, Rodney A"
  4. AU="Bakthavatsalu, Maheshwar"
  5. AU="Fussner, Steven"
  6. AU="Dolsten, Mikael"
  7. AU="Sarnyai, Zoltán"
  8. AU=Dongaonkar Ranjeet M
  9. AU="Singh, Leher"
  10. AU="Sevilla Porras, Marta"
  11. AU="Fuller, Chris K"
  12. AU="Vandeloo, Judith"
  13. AU="Meyers, Amanda"
  14. AU="Jiménez-Bambague, Eliana M"
  15. AU="Turner, J C"
  16. AU="Moore, C J" AU="Moore, C J"
  17. AU="Leresche, Téa"
  18. AU=Astrom Siv AU=Astrom Siv
  19. AU="Di Meglio, Florent"
  20. AU=Simon H U
  21. AU=Croucher P I
  22. AU="Jasti, Madhu"

Suchergebnis

Treffer 1 - 10 von insgesamt 143

Suchoptionen

  1. Artikel ; Online: Towards the rapid detection of haze-forming proteins.

    Cetó, Xavier / McRae, Jacqui M / Mierczynska-Vasilev, Agnieszka / Voelcker, Nicolas H / Prieto-Simón, Beatriz

    Talanta

    2023  Band 268, Heft Pt 1, Seite(n) 125305

    Abstract: Protein haze in white wine can be a serious quality defect because consumers perceive hazy wines as "spoiled". Unfortunately, a specific method for the detection, or selective treatment, of such proteins in affected wines does not exist. Herein we ... ...

    Abstract Protein haze in white wine can be a serious quality defect because consumers perceive hazy wines as "spoiled". Unfortunately, a specific method for the detection, or selective treatment, of such proteins in affected wines does not exist. Herein we investigate on the development of an easy-to-use sensor device that allows detection of haze-forming proteins (HFPs). Such a device is expected to overcome the limitations of the "heat test" currently used to assess the protein content in wine and the amount of bentonite needed to remove such proteins. To this aim, three different approaches were explored. Firstly, an impedimetric immunosensor against chitinases was developed and its performance assessed. Secondly, the exploitation of the dual role of HFPs as biorecognition element and analyte to develop an impedimetric biosensor was evaluated, in what can be considered a very unique strategy, representing a new paradigm in biosensing. Lastly, Fourier transform infrared (FT-IR) spectra were collected for various wine samples and chemometric tools such as discrete wavelet transform (DWT) and artificial neural networks (ANNs) were used to achieve the quantification of HFPs. Detection of HFPs at the μg/L level was achieved with both impedimetric biosensors, whereas the FT-IR-based approach allowed their quantification at the mg/L level in wine samples directly. The sensitivity of the developed methods may enable the rapid assessment of wine protein content.
    Mesh-Begriff(e) Vitis ; Biosensing Techniques ; Spectroscopy, Fourier Transform Infrared ; Plant Proteins ; Immunoassay ; Wine/analysis
    Chemische Substanzen Plant Proteins
    Sprache Englisch
    Erscheinungsdatum 2023-10-11
    Erscheinungsland Netherlands
    Dokumenttyp Journal Article
    ZDB-ID 1500969-5
    ISSN 1873-3573 ; 0039-9140
    ISSN (online) 1873-3573
    ISSN 0039-9140
    DOI 10.1016/j.talanta.2023.125305
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: COVID-19 and immunothrombosis: Pathophysiology and therapeutic implications.

    Lim, Ming Sheng / Mcrae, Simon

    Critical reviews in oncology/hematology

    2021  Band 168, Seite(n) 103529

    Abstract: The coagulopathy of COVID-19 is characterised by significantly elevated D Dimer and fibrinogen, mild thrombocytopenia and a mildly prolonged PT/APTT. A high incidence of thrombotic complications occurs despite standard thromboprophylaxis. The evidence to ...

    Abstract The coagulopathy of COVID-19 is characterised by significantly elevated D Dimer and fibrinogen, mild thrombocytopenia and a mildly prolonged PT/APTT. A high incidence of thrombotic complications occurs despite standard thromboprophylaxis. The evidence to date supports immunothrombosis as the underlying mechanism for this coagulopathy which is triggered by a hyperinflammatory response and endotheliopathy. A hypercoagulable state results from endothelial damage/activation, complement activation, platelet hyperactivity, release of Extracellular Neutrophil Traps, activation of the coagulation system and a "hypofibrinolytic" state. Significant cross-talk occurs between the innate/adaptive immune system, endothelium and the coagulation system. D dimer has been shown to be the most reliable predictor of disease severity, thrombosis, and overall survival. In this context, targeting pathways upstream of coagulation using novel or repurposed drugs alone or in combination with other anti-thrombotic agents may be a rational approach to prevent the mortality/morbidity due to COVID-19 associated coagulopathy.
    Mesh-Begriff(e) Anticoagulants ; COVID-19 ; Humans ; SARS-CoV-2 ; Thromboinflammation ; Venous Thromboembolism
    Chemische Substanzen Anticoagulants
    Sprache Englisch
    Erscheinungsdatum 2021-11-17
    Erscheinungsland Netherlands
    Dokumenttyp Journal Article ; Review
    ZDB-ID 605680-5
    ISSN 1879-0461 ; 0737-9587 ; 1040-8428
    ISSN (online) 1879-0461
    ISSN 0737-9587 ; 1040-8428
    DOI 10.1016/j.critrevonc.2021.103529
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Dating in the Dark: Elevated Substitution Rates in Cave Cockroaches (Blattodea: Nocticolidae) Have Negative Impacts on Molecular Date Estimates.

    Kovacs, Toby G L / Walker, James / Hellemans, Simon / Bourguignon, Thomas / Tatarnic, Nikolai J / McRae, Jane M / Ho, Simon Y W / Lo, Nathan

    Systematic biology

    2024  

    Abstract: Rates of nucleotide substitution vary substantially across the Tree of Life, with potentially confounding effects on phylogenetic and evolutionary analyses. A large acceleration in mitochondrial substitution rate occurs in the cockroach family ... ...

    Abstract Rates of nucleotide substitution vary substantially across the Tree of Life, with potentially confounding effects on phylogenetic and evolutionary analyses. A large acceleration in mitochondrial substitution rate occurs in the cockroach family Nocticolidae, which predominantly inhabit subterranean environments. To evaluate the impacts of this among-lineage rate heterogeneity on estimates of phylogenetic relationships and evolutionary timescales, we analysed nuclear ultraconserved elements (UCEs) and mitochondrial genomes from nocticolids and other cockroaches. Substitution rates were substantially elevated in nocticolid lineages compared with other cockroaches, especially in mitochondrial protein-coding genes. This disparity in evolutionary rates is likely to have led to different evolutionary relationships being supported by phylogenetic analyses of mitochondrial genomes and UCE loci. Furthermore, Bayesian dating analyses using relaxed-clock models inferred much deeper divergence times compared with a flexible local clock. Our phylogenetic analysis of UCEs, which is the first genome-scale study to include all thirteen major cockroach families, unites Corydiidae and Nocticolidae and places Anaplectidae as the sister lineage to the rest of Blattoidea. We uncover an extraordinary level of genetic divergence in Nocticolidae, including two highly distinct clades that separated ~115 million years ago despite both containing representatives of the genus Nocticola. The results of our study highlight the potential impacts of high among-lineage rate variation on estimates of phylogenetic relationships and evolutionary timescales.
    Sprache Englisch
    Erscheinungsdatum 2024-02-06
    Erscheinungsland England
    Dokumenttyp Journal Article
    ZDB-ID 1482572-7
    ISSN 1076-836X ; 1063-5157
    ISSN (online) 1076-836X
    ISSN 1063-5157
    DOI 10.1093/sysbio/syae002
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: Prospective cohort study on the use of low molecular weight heparin calibrated anti-Xa assay for measurement of direct oral Xa inhibitors in ex vivo patient samples.

    Lim, Ming Sheng / Hayes, Robert / Sharma, Archna / Kitiponchai, Tanun / Mohamed, Muhajir / Mcrae, Simon

    Pathology

    2022  Band 54, Heft 5, Seite(n) 599–605

    Abstract: Drug-specific anti-Xa chromogenic assays are recommended for measurement of direct anti-Xa inhibitor levels but are not routinely available in many institutions. We performed a prospective study to determine: (1) the relationship between low molecular ... ...

    Abstract Drug-specific anti-Xa chromogenic assays are recommended for measurement of direct anti-Xa inhibitor levels but are not routinely available in many institutions. We performed a prospective study to determine: (1) the relationship between low molecular weight heparin (LMWH) calibrated anti-Xa measurements and apixaban or rivaroxaban levels measured using drug-specific anti-Xa assays and, (2) if a LMWH calibrated anti-Xa assay can be used to detect clinically significant apixaban or rivaroxaban levels. Haematology outpatients on rivaroxaban or apixaban for at least 72 h were recruited for this study. Anti-Xa LMWH assay was performed using the Innovance Heparin Anti-Xa kit/calibrator. Drug-specific levels were determined using STA-Liquid anti-Xa kit/STA-Apixaban or STA-Rivaroxaban calibrators. Serial dilutions with pooled normal plasma were performed for specimens with anti-Xa LMWH activity greater than 1.50 ng/mL to obtain anti-Xa levels within the reportable range (0.10-1.50 ng/mL) and multiplied by the dilution factor to determine actual anti-Xa level. Seventy-five (39 rivaroxaban, 36 apixaban) specimens from 67 patients (mean age 60.3 years; 53.3% males) were available for analysis. Rivaroxaban levels ranged from <25 to 500 ng/mL while apixaban levels ranged from <20 to 236.1 ng/mL. For both rivaroxaban and apixaban, there was linear and good correlation (R
    Mesh-Begriff(e) Anticoagulants/pharmacology ; Blood Coagulation Tests ; Factor Xa Inhibitors ; Female ; Heparin, Low-Molecular-Weight ; Humans ; Male ; Middle Aged ; Prospective Studies ; Pyridones ; Rivaroxaban/pharmacology
    Chemische Substanzen Anticoagulants ; Factor Xa Inhibitors ; Heparin, Low-Molecular-Weight ; Pyridones ; Rivaroxaban (9NDF7JZ4M3)
    Sprache Englisch
    Erscheinungsdatum 2022-04-09
    Erscheinungsland England
    Dokumenttyp Journal Article
    ZDB-ID 7085-3
    ISSN 1465-3931 ; 0031-3025
    ISSN (online) 1465-3931
    ISSN 0031-3025
    DOI 10.1016/j.pathol.2022.01.004
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: Prolongation of prothrombin time in the presence of rivaroxaban: is this the only cause?

    Sagheer, Safoorah / McRae, Simon

    Internal medicine journal

    2017  Band 47, Heft 2, Seite(n) 225–227

    Abstract: Rivaroxaban is an oral direct Xa inhibitor that can lead to prolongation of prothrombin time and activated partial thromboplastin time. However, these basic coagulation tests are not specific for the anticoagulant effect of rivaroxaban and other ... ...

    Abstract Rivaroxaban is an oral direct Xa inhibitor that can lead to prolongation of prothrombin time and activated partial thromboplastin time. However, these basic coagulation tests are not specific for the anticoagulant effect of rivaroxaban and other confounding factors should be considered while interpreting the test results. We report a case of a patient on rivaroxaban, where underlying factor VII deficiency led to confusion in the interpretation of prothrombin time results and delayed her surgery.
    Mesh-Begriff(e) Aged, 80 and over ; Atrial Fibrillation/complications ; Blood Coagulation/drug effects ; Factor Xa Inhibitors/adverse effects ; Female ; Humans ; Partial Thromboplastin Time ; Prothrombin Time ; Rivaroxaban/adverse effects ; Stroke/blood ; Stroke/drug therapy
    Chemische Substanzen Factor Xa Inhibitors ; Rivaroxaban (9NDF7JZ4M3)
    Sprache Englisch
    Erscheinungsdatum 2017-02
    Erscheinungsland Australia
    Dokumenttyp Case Reports ; Journal Article
    ZDB-ID 2045436-3
    ISSN 1445-5994 ; 1444-0903
    ISSN (online) 1445-5994
    ISSN 1444-0903
    DOI 10.1111/imj.13343
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: An observational study of physical, cognitive and social activities in rehabilitation inpatients.

    McRae, Prue / Bew, Paul / Smith, Simon / Mudge, Alison

    Australasian journal on ageing

    2020  Band 39, Heft 3, Seite(n) 217–224

    Abstract: Objectives: To describe patient behaviour related to mobility in a rehabilitation inpatient setting and compare intensive and Transition Care Program (TCP, slow-stream rehabilitation) models.: Methods: Prospective cross-sectional design including ... ...

    Abstract Objectives: To describe patient behaviour related to mobility in a rehabilitation inpatient setting and compare intensive and Transition Care Program (TCP, slow-stream rehabilitation) models.
    Methods: Prospective cross-sectional design including weekday and weekend sampling in two rehabilitation wards (one intensive and one TCP) in a publicly funded facility. A single trained observer undertook behavioural mapping, observing patient location, mobility, activity and company on all inpatients 8 am-4 pm using a structured 2-minute observation protocol. Observations were summarised and compared between wards.
    Results: We observed 74 inpatients on a Tuesday and 77 on a Sunday. Participants spent 7% (median) of daytime standing or walking. They spent 62%-87% in their room, 22%-40% sleeping or resting and 74%-86% alone. The only significant difference between wards was time spent off ward on Tuesday. Activity was lower on Sunday.
    Conclusions: Time spent in physical, cognitive and social activities is low in inpatient rehabilitation and TCP wards.
    Mesh-Begriff(e) Cognition ; Cross-Sectional Studies ; Humans ; Inpatients ; Prospective Studies ; Walking
    Sprache Englisch
    Erscheinungsdatum 2020-02-25
    Erscheinungsland Australia
    Dokumenttyp Journal Article ; Observational Study
    ZDB-ID 1457406-8
    ISSN 1741-6612 ; 0726-4240 ; 1440-6381
    ISSN (online) 1741-6612
    ISSN 0726-4240 ; 1440-6381
    DOI 10.1111/ajag.12785
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel: Treatment options for venous thromboembolism: lessons learnt from clinical trials.

    McRae, Simon

    Thrombosis journal

    2014  Band 12, Heft 1, Seite(n) 27

    Abstract: Venous thromboembolism (VTE), comprising deep vein thrombosis and pulmonary embolism, is a common condition associated with a significant clinical and economic burden. Anticoagulant therapy is the mainstay of treatment for VTE, having been shown to ... ...

    Abstract Venous thromboembolism (VTE), comprising deep vein thrombosis and pulmonary embolism, is a common condition associated with a significant clinical and economic burden. Anticoagulant therapy is the mainstay of treatment for VTE, having been shown to reduce the risk of death in patients with pulmonary embolism, and recurrence or extension of thrombi in patients with deep vein thrombosis during the initial treatment period. Long-term anticoagulation is indicated in some individuals with VTE, depending on individual risk of VTE recurrence and anticoagulant-related bleeding. Management of VTE in clinical practice is often complex because patients' characteristics and treatment needs may differ considerably from those encountered in clinical trials. Current guidelines recommend the use of either low molecular weight heparins or fondaparinux overlapping with and followed by a vitamin K antagonist for the initial treatment of VTE, with the vitamin K antagonist continued when long-term anticoagulation is required. These traditional anticoagulants have practical limitations that have led to the development of direct oral anticoagulants that directly target either Factor Xa or thrombin and are administered at a fixed dose without the need for routine coagulation monitoring. This review discusses practical considerations for hospital physicians and haematologists in the management of VTE treatment, including the potential for the direct oral anticoagulants to simplify treatment.
    Sprache Englisch
    Erscheinungsdatum 2014-12-08
    Erscheinungsland England
    Dokumenttyp Journal Article
    ZDB-ID 2118392-2
    ISSN 1477-9560
    ISSN 1477-9560
    DOI 10.1186/s12959-014-0027-8
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Artikel ; Online: Staff knowledge, attitudes and behaviours related to mobilisation in a rehabilitation setting: Short report of a multidisciplinary survey.

    Mudge, Alison M / Bew, Paul / Smith, Simon / McRae, Prue

    Australasian journal on ageing

    2020  Band 39, Heft 3, Seite(n) 225–229

    Abstract: Objectives: Regular mobilising is important in inpatient rehabilitation, but objective measurements show low patient mobility. We sought to understand multidisciplinary staff perspectives on barriers and enablers to mobility in a rehabilitation setting.! ...

    Abstract Objectives: Regular mobilising is important in inpatient rehabilitation, but objective measurements show low patient mobility. We sought to understand multidisciplinary staff perspectives on barriers and enablers to mobility in a rehabilitation setting.
    Methods: A validated barriers survey (standardised score 0-100, higher representing greater barriers) was distributed to 99 clinical staff on two wards at a single rehabilitation facility.
    Results: The survey was completed by 83 staff (52 nurses, 25 allied health professionals, 4 therapy assistants and 2 medical officers) and identified barriers in behaviour (mean 39, SD 11), attitudes (mean 34, SD 12) and knowledge (mean 23, SD 18). Prominent perceived barriers were nursing workload, unclear responsibility for mobilising, risk of staff injury, patient motivation and family participation; perceived enablers were good knowledge, positive outcome expectations and team communication.
    Conclusions: These barriers can inform locally tailored strategies to improve rehabilitation patient mobility.
    Mesh-Begriff(e) Allied Health Personnel ; Attitude of Health Personnel ; Health Knowledge, Attitudes, Practice ; Humans ; Inpatients ; Surveys and Questionnaires
    Sprache Englisch
    Erscheinungsdatum 2020-04-12
    Erscheinungsland Australia
    Dokumenttyp Journal Article
    ZDB-ID 1457406-8
    ISSN 1741-6612 ; 0726-4240 ; 1440-6381
    ISSN (online) 1741-6612
    ISSN 0726-4240 ; 1440-6381
    DOI 10.1111/ajag.12793
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel ; Online: The Australian experience with switching to extended half-life factor VIII and IX concentrates: On behalf of the Australian Haemophilia Centre Directors' Organisation.

    Brennan, Yvonne / Parikh, Sumit / McRae, Simon / Tran, Huyen

    Haemophilia : the official journal of the World Federation of Hemophilia

    2020  Band 26, Heft 3, Seite(n) 529–535

    Abstract: Introduction: Extended half-life (EHL) factor (F) VIII and FIX concentrates became available to selected haemophilia A (HA) and haemophilia B (HB) patients in Australia in March 2018.: Aim: To determine factor utilization and bleeding outcomes during ...

    Abstract Introduction: Extended half-life (EHL) factor (F) VIII and FIX concentrates became available to selected haemophilia A (HA) and haemophilia B (HB) patients in Australia in March 2018.
    Aim: To determine factor utilization and bleeding outcomes during the first 6 months of prophylaxis with EHL concentrates, and compare it to the last 6 months of prophylaxis with standard half-life (SHL) concentrates.
    Methods: A national, retrospective study was performed using data extracted from the Australian Bleeding Disorders Registry (ABDR). Patients with ≥3 months of EHL exposure were analysed.
    Results: A total of 129 HA patients (86 Adynovate, 43 Eloctate) and 64 HB (Alprolix) patients were included in the study. For HA, switching to EHL FVIII resulted in decreased injection frequency (3 to 2 per week), improved 'reduced adherence' rates (18% to 7%), decreased median annualized bleeding rate (ABR; 2.0 to 0.0) and increased proportion of patients with zero bleeds (44% to 64%). Actual factor utilization increased by 20 IU/kg/wk on Adynovate and 4 IU/kg/wk on Eloctate. For HB, switching to EHL FIX resulted in decreased injection frequency (2 to 1 per week), improved 'reduced adherence' rates (35% to 11%), decreased median ABR (3.0 to 2.0) and increased proportion of patients with zero bleeds (31% to 46%). Actual factor utilization decreased by 4 IU/kg/wk. There was no clinically significant inhibitor development.
    Conclusion: Compared to SHL, EHL FVIII resulted in improved bleeding outcomes, albeit at the expense of increased factor utilization. EHL FIX resulted in improved bleeding outcomes despite decreased factor utilization.
    Mesh-Begriff(e) Adult ; Australia ; Child ; Child, Preschool ; Factor IX/pharmacology ; Factor IX/therapeutic use ; Factor VIII/pharmacology ; Factor VIII/therapeutic use ; Half-Life ; Hemophilia A/drug therapy ; Humans ; Immunoglobulin Fc Fragments/pharmacology ; Immunoglobulin Fc Fragments/therapeutic use ; Recombinant Fusion Proteins/pharmacology ; Recombinant Fusion Proteins/therapeutic use ; Retrospective Studies ; Young Adult
    Chemische Substanzen Immunoglobulin Fc Fragments ; Recombinant Fusion Proteins ; factor IX Fc fusion protein ; Factor VIII (9001-27-8) ; Factor IX (9001-28-9)
    Sprache Englisch
    Erscheinungsdatum 2020-04-03
    Erscheinungsland England
    Dokumenttyp Journal Article
    ZDB-ID 1229713-6
    ISSN 1365-2516 ; 1351-8216 ; 1355-0691
    ISSN (online) 1365-2516
    ISSN 1351-8216 ; 1355-0691
    DOI 10.1111/hae.13970
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: Overweight and obese middle-aged women have increased risk of venous thromboembolism, particularly following surgery.

    McRae, Simon

    Evidence-based nursing

    2013  Band 16, Heft 2, Seite(n) 38–39

    Abstract: Implications for practice and research: Obesity is associated with an increased risk of venous thromboembolism (VTE) including both spontaneous and postoperative events. Further research is needed regarding factors responsible for the increase in ... ...

    Abstract Implications for practice and research: Obesity is associated with an increased risk of venous thromboembolism (VTE) including both spontaneous and postoperative events. Further research is needed regarding factors responsible for the increase in postoperative VTE in overweight patients, and whether management should be altered (eg, increased focus on postoperative mobilisation,altered doses of prophylactic anticoagulants, lower threshold for starting prophylactic anticoagulation for minor surgical procedures). Weight loss prior to surgery may reduce risk of venous thrombosis.
    Sprache Englisch
    Erscheinungsdatum 2013-04
    Erscheinungsland England
    Dokumenttyp Comment ; Journal Article
    ZDB-ID 1425988-6
    ISSN 1468-9618 ; 1367-6539
    ISSN (online) 1468-9618
    ISSN 1367-6539
    DOI 10.1136/eb-2012-100841
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang